Axiogenesis Cor.At mESC cardiomyocytes

Monday, 21 June, 2010 | Supplied by: Lonza Australia Pty Ltd


Msf249

Embryonic stem cell-derived cardiomyocytes have many of the phenotypic properties of primary cardiomyocytes and show great potential to model human diseases. The Cor.At cells are cardiomyocytes derived from transgenic mouse embryonic stem cells and are available cryopreserved in ampoules.

The cells are highly pure with ampoules containing 99% cardiomyocytes. Their minimal lot-to-lot variation is claimed to give consistent performance and the standardised production process ensures stable supply.

The cardiomyocytes are a good predictive model with relevant background including all important ion channels well characterised.

They are suitable for applications including: electrophysiology (patch clamp, microelectrode arrays, Ca2+ flux analysis), non-arrhythmic cardiotoxicity (cell viability, label-free analysis, troponin release), drug profiling and target discovery (hypertrophy, gene expression, transfection, tissue engineering).

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

Avanti Polar Lipids SPLASH LipidoMix Mass Spectrometry Standard

The SPLASH LipidoMix standard includes all of the major lipid classes at ratios relative to human...

HEMCO Emergency Shower Decontamination Booth

HEMCO Emergency Shower Decontamination Booths are fully assembled and ready for installation to...

Cayman Chemical single-use polyunsaturated fatty acids (PUFAs)

Cayman Chemical's peroxide-free fatty acids are packaged in small aliquots in individual,...


  • All content Copyright © 2016 Westwick-Farrow Pty Ltd